The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index; 21 of the 46 sources its claims cite were checked for support.
Loss of Extracellular Signal-Regulated Kinase 1/2 in the Retinal Pigment Epithelium Leads to RPE65 Decrease and Retinal Degeneration
Open accessAbstract
Recent work suggested that the activity of extracellular signal-regulated kinase 1/2 (ERK1/2) is increased in the retinal pigment epithelium (RPE) of age-related macular degeneration (ARMD) patients and therefore could be an attractive therapeutic target. Notably, ERK1/2 pathway inhibitors are used in cancer therapy, with severe and noncharacterized ocular side effects. To decipher the role of ERK1/2 in RPE cells, we conditionally disrupted the Erk1 and Erk2 genes in mouse RPE. The loss of ERK1/2 activity resulted in a significant decrease in the level of RPE65 expression, a decrease in ocular retinoid levels concomitant with low visual function, and a rapid disorganization of RPE cells, ultimately leading to retinal degeneration. Our results identify the ERK1/2 pathway as a direct regulator of the visual cycle and a critical component of the viability of RPE and photoreceptor cells. Moreover, our results caution about the need for a very fine adjustment of kinase inhibition in cancer or ARMD treatment in order to avoid ocular side effects.
Overview
CoChat Summary
TL;DR
RPE-specific deletion of ERK1/2 in adult mice causes early RPE65 downregulation via reduced C-FOS/FRA-1 binding to an AP-1 site, retinoid depletion, and progressive RPE/retinal degeneration. These findings argue that ERK1/2 inhibition proposed for ARMD treatment must be reevaluated because ERK1/2 is needed for RPE maintenance and visual function.
Key findings
- RPE-DKO mice showed fundus depigmentation, significant reduction of all retinal and choroidal layers by OCT at 4 months, and impaired ERG at 2 months, with absence or severe reduction of a and b waves under scotopic 50 mcd s/m² and absence of stimulation under photopic 10 mcd s/m².
- Ocular retinoids were depleted: dark-adapted retinas had decreases of more than half in 11-*cis*-retinal and all-*trans*-retinal, choroidal retinyl esters were significantly reduced, and light-exposed all-*trans*-retinol and retinyl esters were significantly lower than controls.
- Retinal degeneration was severe: ONL and INL thicknesses were reduced by 50% after 2 months and up to 70% after 4 months; GNAT2 was reduced by more than 60% at 4 months; qPCR cone markers decreased 60–80% at 4 months; at 1 year the ONL disappeared, the INL was drastically thinned, and no cone or rod staining remained.
- Mechanistically, RPE65 mRNA and protein were decreased by about 50% at 1 month and already at 2 weeks; LRAT was mislocalized; the RPE65 promoter AP-1 site was required for U0126 sensitivity; and C-FOS and FRA-1 binding/protein levels were reduced in RPE-DKO RPE and after ERK1/2 inhibition.
Methods
- Mice: *Erk1*−/−; *Erk2* f/f mice were crossed with VMD2-rtTA/TRE-Cre mice; two intraperitoneal injections of 10 μg doxycycline 1 week apart at 2 months induced RPE-specific *Erk2* deletion (RPE-DKO), while controls received PBS. Analyses were at 2 weeks, 1 month, 2 months, 4 months, or 1 year after injection.
- Functional and structural assays: fundus photography, OCT, scotopic and photopic ERG, immunohistochemistry, TUNEL, electron microscopy, flat-mount RPE-choroid analysis, Western blot, qPCR, and HPLC retinoid measurements.
- Cell and molecular assays: HEK293T/HEK293 and ARPE19 cells; luciferase reporter assays with RPE65 or LRAT promoter constructs and an AP-1-deleted RPE65 construct; treatment with U0126 (10 nM) or PD0325901 (2 μM) for 24 h; AP-1 binding ELISA and EMSA.
Limitations
- Stated: The authors cannot exclude that other regulatory elements close to the AP-1 site were also deleted from the RPE65 promoter reporter, which could explain the low promoter activity observed without the AP-1 sequence.
- Stated: They cannot totally exclude that ERK1/2 was also depleted in some IPL vessels because of ectopic Cre expression in IPL vessels (but not choroidal vessels) in certain mice, which may impact INL degeneration; further analyses are required to decipher the mechanisms leading to INL degeneration.
- Evident from the text: Some supporting observations are reported as data not shown (e.g., STRA6 decrease and control retinal degeneration data), and the GNAT1 immunostaining decrease was not confirmed by qPCR or Western blot because the GNAT1/tubulin ratio was unchanged.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![FIG 2 Loss of ERK1/2 in the RPE leads to vision impairment. (A) Representative fundus images of CTL and RPE-DKO mice at 2 or 4 months. (B) Representative OCT images of CTL and RPE-DKO mice at 4 months. (C) Graphs of the scotopic (n = 10) and photopic (n = 4) ERG responses (b wave) of CTL and RPE-DKO mice at 2 months. (*, P < 0.05; **, P < 0.001). The right panel shows the scotopic (50 mcd s/m2) and photopic (10 mcd s/m2) ERG responses of CTL and RPE-DKO mice. (D) Chromatographs and quantification of retinoids (retinol [ROL] and retinal [RAL]) measured in the retina and in the RPE-choroid from mice at 1 month, which were dark adapted for 16 h, or measured in whole eyes (containing the retina, RPE, and choroid) from mice (same conditions) exposed to 1,000 mA of light for 2 h.](https://figures.cochat.ai/paper-figures/58ad19e4e4c449ecb7c265a139c9be9b/loss-of-extracellular-signal-regulated-kinase-1-2-in-the-retinal-pigment-figure-2.jpg)





Verification
Claims the paper makes
19 Valid · 1 Not valid · 16 Not checked · 72 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“previous work from our laboratory showed that A2E induces a strong decrease in extracellular signal-regulated kinase 1/2 (ERK1/2) activity in polarized ARPE19 and isolated mouse RPE cells”
What the sources say
- Supportedcites [9] source
The Results section reports a marked decrease of more than 50% in ERK1/2 activity in polarized ARPE19 cells after prolonged A2E exposure, and a similar decrease in isolated mouse RPE cells. The Discussion confirms the finding in both cell types; the decrease was observed with long-term exposure, not the short-term treatment tested. (LLM, conf=0.92)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“We previously showed that the inhibition of the ERK1/2 pathway in ARPE19 cells as well as in isolated mouse RPE cells leads to a reduction of Rpe65 mRNA expression”
What the sources say
- Partly supportedcites [9] sourceExperimental — accuracy not yet measured
The Results (Figure 4B–C; page not provided) report reduced RPE65 mRNA in A2E-treated polarized ARPE19 cells, alongside reduced ERK1/2 activity. In isolated mouse RPE cells, the reported RPE65 reduction is in protein, not mRNA. These results also do not establish that ERK1/2 inhibition itself caused the mRNA reduction. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“the inhibition of ERK1/2 leads to a significant decrease in the level of retinal pigment epithelium-specific protein of 65 kDa (RPE65)”
What the sources say
- Supportedcites [9] source
The Abstract (page unavailable) states that A2E, via decreased ERK1/2 activity, significantly decreases RPE65 expression in ARPE19 cells and isolated mouse RPE. The Results (Figure 4; page unavailable) report decreased ERK1/2 activity alongside decreased RPE65 protein in isolated mouse RPE cells. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Even if Cre expression is observed specifically in RPE cells, as shown for Cre-tdTomato mice ( Fig. 1 ) and as previously described ( 30 ),”
What the sources say
- Partly supportedcites [30] sourceExperimental — accuracy not yet measured
The Results and Discussion describe Cre activity as restricted to RPE cells in the retina, supporting the cited point. They also report weak expression in the optic nerve, so the source does not support an unqualified claim that expression occurs only in RPE cells. The Cre-tdTomato observation is attributed to the citing paper’s own Figure 1, not to this source. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In addition, the inhibition of the ERK1/2 pathway by U0126 also induces a significant decrease in the level of RPE65 expression ( 9 ).”
What the sources say
- Partly supportedcites [9] sourceExperimental — accuracy not yet measured
The Results (Figure 4; page not specified) report that A2E treatment reduced ERK1/2 activity and significantly decreased RPE65 expression. The paper identifies U0126 as an ERK1/2 inhibitor in Materials and Methods, but the passages do not show that U0126 itself decreased RPE65 expression. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
42 more claims · 2 with their cited sources checked
Create a free account to see all 108 claims and every source verdict.
- Probably not a substantial claim. 26
- It may state two separate claims as one. 46
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These effects seem to be dose-dependent, however, and reliant on a non-total ERK1/2 inhibition, since specific ablation of ERK1/2 in mouse RPE cells leads to RPE cell death and retinal degeneration [ 44 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“The second consequence includes changes in the morphology of the RPE and in the RPE cell death process, which appears later, 2 months after Cre induction, when most of the hallmarks of retinal degeneration are visible in the eyes of RPE-DKO mice.”
“The loss of vision as well as the pronounced retinal degeneration in these mice prompted us to examine the state of the RPE ultrastructure in RPE-DKO mice at 1 month by EM imaging. An overview of the RPE-retina cell layers showed massive shrinkage of the RPE cell layer, a disruption of Bruch's membrane (BM), and PR degeneration ( Fig. 6A ).”
Citations
Cites
THE USE OF LEAD CITRATE AT HIGH pH AS AN ELECTRON-OPAQUE STAIN IN ELECTRON MICROSCOPY
Reynolds, E. S. (1963) · The Journal of Cell Biology · doi:10.1083/jcb.17.1.208 · Cited by 24,938 · cited 1×
“4% Reynolds’ lead citrate (75) in H2O (Sigma-Aldrich) during 10 min, and rinsed several times with H2O.”
MethodRepertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
A robust and high-throughput Cre reporting and characterization system for the whole mouse brain
Madisen, L., Zwingman, T. A., Sunkin, S. M., Oh, S. W., Zariwala, H. A., Gu, H., Ng, L. L., Palmiter, R. D., Hawrylycz, M. J., Jones, A. R., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2467 · Cited by 6,907 · cited 2×
“Cre-tdTomato mice were created by crossbreeding VMD2-rtTA/TRE-Cre mice with tdTomato mice (31) to set up the Dox injection protocol and visualize Cre expression.”
MethodActivation and function of the MAPKs and their substrates, the MAPK-activated protein kinases
Cargnello, M., & Roux, P. P. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00031-10 · Cited by 3,274
The Retinal Pigment Epithelium in Visual Function
Strauss, O. (2005) · Physiological Reviews · doi:10.1152/physrev.00021.2004 · Cited by 2,828 · cited 1×
“Accordingly, interactions of PRs with the RPE are essential for PR survival (67).”
BackgroundPathological roles of MAPK signaling pathways in human diseases
Kim, E. K., & Choi, E.-J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.009 · Cited by 2,472
Hyperactive Ras in developmental disorders and cancer
Schubbert, S., Shannon, K., & Bollag, G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2109 · Cited by 1,583
Mammalian MAPK Signal Transduction Pathways Activated by Stress and Inflammation: A 10-Year Update
Kyriakis, J. M., & Avruch, J. (2012) · Physiological Reviews · doi:10.1152/physrev.00028.2011 · Cited by 1,466
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265 · cited 2×
“This pathology is characterized by the presence of soft and/or hard drusen (extracellular debris and deposits), hyper- and hypopigmentation of retinal pigment epithelium (RPE) cells, RPE and photoreceptor (PR) apoptosis, as well as choroidal neovascularization (CNV) (1).”
BackgroundTargeting RAS–ERK signalling in cancer: promises and challenges
Samatar, A. A., & Poulikakos, P. I. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4281 · Cited by 1,163
Cited by
Yang, Y.-C., Chien, Y., Yarmishyn, A. A., Lim, L.-Y., Tsai, H.-Y., Kuo, W., Tsai, P., Yang, S.-H., Hong, S.-I., Chen, S., et al. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.06.004 · Cited by 73
“ERK was completely depleted by conditional knockout of Erk1 and Erk2 genes in the mouse RPE, which led to diminished RPE65 expression and induced retinal degeneration [69].”
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
“These effects seem to be dose-dependent, however, and reliant on a non-total ERK1/2 inhibition, since specific ablation of ERK1/2 in mouse RPE cells leads to RPE cell death and retinal degeneration [44].”
BackgroundGlabridin Attenuates the Retinal Degeneration Induced by Sodium Iodate In Vitro and In Vivo
Aung, K. H., Liu, H., Ke, Z., Jiang, S., & Huang, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.566699 · Cited by 20
“The ERK1/2 pathway is assumed to be a direct regulator of the visual cycle and a critical component of the viability of RPE and photoreceptor cells (Pyakurel et al., 2017).”
BackgroundHuang, Y., Chen, B.-C., Chang, K., Hsieh, M., Sheu, G., Hsiao, C., & Tsai, N. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121815 · Cited by 18
Hsu, D., Kwon, J. H., Ng, R., Makita, S., Yasuno, Y., Šarunic, M. V., & Ju, M. J. (2020) · Biomedical Optics Express · doi:10.1364/boe.403209 · Cited by 18
Metadata
- Authors
- Pyakurel, A., Balmer, D., Saba-El-Leil, M. K., Kizilyaprak, C., Daraspe, J., Humbel, B. M., Voisin, L., Le, Y. Z., von Lintig, J., Meloche, S., & Roduit, R.
- Affiliations
- Institut de Recherche en Opthalmologie (CH)
- Institute for Research in Immunology and Cancer (CA)
- University of Lausanne (CH)
- University of Oklahoma Health Sciences Center (US)
- Department of Pharmacology, School of Medicine, Case Western Reserve University
- Corresponding author
- Roduit, Raphaël
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2017-12-01
- Volume
- 37
- Issue
- 24
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC5705814
- OpenAlex
- W2767028946
- Cited by
- 20
- References
- 76
- Citations by year
- 2025: 2 · 2024: 8 · 2023: 5 · 2021: 1 · 2020: 4
- FWCI
- 0.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular and Cellular Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- SERVAL (Université de Lausanne) (publishedVersion, cc-by)
- IRIS (submittedVersion, cc-by)
- SERVAL (Université de Lausanne) (submittedVersion, other-oa)
- Funders
- Gelbert Foundation
- Art & Vie Foundation
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Drug-Induced Ocular Toxicity
- Keywords
- ERK signaling, retinal pigment epithelium, RPE65, retinal degeneration, age-related macular degeneration, visual cycle, conditional gene disruption, kinase inhibitors, ocular adverse effects
- MeSH terms
- Retinoid Isomerohydrolase, Animals, Macular Degeneration, Retina, Retinoids, Mice, Knockout, cis-trans-Isomerases, Mitogen-Activated Protein Kinase 1, MAP Kinase Signaling System, Models, Animal, Mice, Retinal Pigment Epithelium
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Loss of Extracellular Signal-Regulated Kinase 1/2 in the Retinal Pigment Epithelium Leads to RPE65 Decrease and Retinal Degeneration. https://app.cochat.ai/papers/10.1128/mcb.00295-17
- The paper
- Pyakurel, A., Balmer, D., Saba-El-Leil, M. K., Kizilyaprak, C., Daraspe, J., Humbel, B. M., Voisin, L., Le, Y. Z., von Lintig, J., Meloche, S., & Roduit, R. (2017). Loss of Extracellular Signal-Regulated Kinase 1/2 in the Retinal Pigment Epithelium Leads to RPE65 Decrease and Retinal Degeneration. Molecular and Cellular Biology. https://doi.org/10.1128/mcb.00295-17
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.